Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NovaMed CEO Mark Lotter On Working With Pharma Distributors In China: An Interview With PharmAsia News

This article was originally published in PharmAsia News

Executive Summary

Shanghai-based NovaMed Pharmaceuticals was founded in August 2005 to provide distribution services for multinational pharmaceutical companies in China. NovaMed has signed China deals with several multinationals, including Baxter, Pfizer and Sanofi-Aventis. NovaMed Founder and CEO Mark Lotter recently participated in an email interview with PharmAsia News' Shanghai bureau about the changing contours of the pharmaceutical sector in China.
Advertisement

Related Content

China's Outsource Sales Model Takes A Big Step: SciClone Takes Out NovaMed
China's Outsource Sales Model Takes A Big Step: SciClone Takes Out NovaMed
What's The Winning Strategy In China? Franchises Are Key
What's The Winning Strategy In China? Franchises Are Key
China's Epilepsy Market Growing Rapidly; Attracting More Multinational Companies
China's Epilepsy Market Growing Rapidly; Attracting More Multinational Companies
Sweden’s Orexo Forms Partnership With Shanghai’s NovaMed To Enter Chinese Oncology Market
Sweden’s Orexo Forms Partnership With Shanghai’s NovaMed To Enter Chinese Oncology Market
Pfizer Tries Sales Outsourcing In China
Chinese Health Insurance Ruralization Expands Patient Pool For Clinical Trials
Advertisement
UsernamePublicRestriction

Register

SC069402

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel